Impact of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in patients with chronic kidney disease: propensity score matched analysis

• Wen Sun,
• Bryan P Yan

Affiliations

Wen Sun

Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China

Bryan P Yan

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong